On 15 January, the two agencies released respective lists of medicines approved last year. The FDA approved 50 novel drugs ...
Zai Lab Limited today announced that China's National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for KarXT for the treatment of schizophrenia in adults. "There ...